Share
Title
Code
Session Type
Track
Channel
Date Time
Local Date Time
Moderators:

2 min
Introduction
Natalia LAUFER, Argentina
Roger LEGRAND, CEA, France
7 min
In-vivo imaging using anti-ENV probes in SIV infected monkeys: a reproducibility study
Michele DI MASCIO, NIAID, United States
Abstract

7 min
Dual IL-10 and PD-1 blockade in SIVmac239 infected macaques promotes sustained virologic control in absence of ART
Zachary STRONGIN, Emory University, United States
Abstract

7 min
Combination therapy with the broadly neutralizing antibody VRC07-523LS and the latency reversal agent Vorinostat fails to substantially reduce latent, resting CD4+ T cell infection or reduce low-level viremia
David Michael MARGOLIS, United States
Abstract

23 min
Live Q&A
Michele DI MASCIO, NIAID, United States
David Michael MARGOLIS, United States
Zachary STRONGIN, Emory University, United States
Roger LEGRAND, CEA, France
Natalia LAUFER, Argentina
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT